Drug disposition model of radiolabeled etelcalcetide in patients with chronic kidney disease and secondary hyperparathyroidism on hemodialysis
Crossref DOI link: https://doi.org/10.1007/s10928-016-9503-z
Published Online: 2017-01-06
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wu, Liviawati
Melhem, Murad
Subramanian, Raju
Wu, Benjamin
Funding for this research was provided by:
Amgen
License valid from 2017-01-06